| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
|
Lancet
|
2002
|
10.48
|
|
2
|
Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08.
|
Lancet
|
2010
|
6.81
|
|
3
|
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America.
|
Lancet
|
2006
|
6.56
|
|
4
|
Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study.
|
Lancet
|
2013
|
5.85
|
|
5
|
Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study.
|
BMJ
|
2007
|
4.92
|
|
6
|
Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial.
|
Lancet
|
2010
|
3.59
|
|
7
|
Active management of the third stage of labour with and without controlled cord traction: a randomised, controlled, non-inferiority trial.
|
Lancet
|
2012
|
2.75
|
|
8
|
Alternative versus standard packages of antenatal care for low-risk pregnancy.
|
Cochrane Database Syst Rev
|
2010
|
2.69
|
|
9
|
Mandatory second opinion to reduce rates of unnecessary caesarean sections in Latin America: a cluster randomised controlled trial.
|
Lancet
|
2004
|
2.59
|
|
10
|
Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries.
|
Bull World Health Organ
|
2006
|
2.50
|
|
11
|
Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?
|
Am J Obstet Gynecol
|
2006
|
2.26
|
|
12
|
Methodological considerations in implementing the WHO Global Survey for Monitoring Maternal and Perinatal Health.
|
Bull World Health Organ
|
2008
|
2.15
|
|
13
|
The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term: a randomized, controlled trial.
|
Pediatrics
|
2006
|
2.12
|
|
14
|
Maternal near miss and maternal death in the World Health Organization's 2005 global survey on maternal and perinatal health.
|
Bull World Health Organ
|
2009
|
1.90
|
|
15
|
Effectiveness of a clinically integrated e-learning course in evidence-based medicine for reproductive health training: a randomized trial.
|
JAMA
|
2012
|
1.79
|
|
16
|
Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial.
|
Lancet
|
2009
|
1.67
|
|
17
|
Accuracy of diagnostic tests to detect asymptomatic bacteriuria during pregnancy.
|
Obstet Gynecol
|
2009
|
1.66
|
|
18
|
World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women.
|
Am J Obstet Gynecol
|
2006
|
1.65
|
|
19
|
Maternal and perinatal health research priorities beyond 2015: an international survey and prioritization exercise.
|
Reprod Health
|
2014
|
1.61
|
|
20
|
Are women and providers satisfied with antenatal care? Views on a standard and a simplified, evidence-based model of care in four developing countries.
|
BMC Womens Health
|
2002
|
1.59
|
|
21
|
Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and preterm delivery: an overview of randomized controlled trials.
|
J Nutr
|
2003
|
1.58
|
|
22
|
Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research.
|
Paediatr Perinat Epidemiol
|
2008
|
1.56
|
|
23
|
One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial.
|
Obstet Gynecol
|
2009
|
1.50
|
|
24
|
Womens' opinions on antenatal care in developing countries: results of a study in Cuba, Thailand, Saudi Arabia and Argentina.
|
BMC Public Health
|
2003
|
1.34
|
|
25
|
Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial.
|
Reprod Health
|
2013
|
1.33
|
|
26
|
Episiotomy rates around the world: an update.
|
Birth
|
2005
|
1.19
|
|
27
|
Heterogeneity of perinatal outcomes in the preterm delivery syndrome.
|
Obstet Gynecol
|
2004
|
1.18
|
|
28
|
Mapping the theories of preeclampsia: the role of homocysteine.
|
Obstet Gynecol
|
2005
|
1.16
|
|
29
|
WHO global survey on maternal and perinatal health in Latin America: classifying caesarean sections.
|
Reprod Health
|
2009
|
1.14
|
|
30
|
The cost-effectiveness of routine versus restrictive episiotomy in Argentina.
|
Am J Obstet Gynecol
|
2002
|
1.10
|
|
31
|
Costs of publicly provided maternity services in Rosario, Argentina.
|
Salud Publica Mex
|
2003
|
1.10
|
|
32
|
Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour.
|
BJOG
|
2002
|
1.07
|
|
33
|
The world health organization multicountry survey on maternal and newborn health: study protocol.
|
BMC Health Serv Res
|
2011
|
1.01
|
|
34
|
Community-based supplementary feeding for promoting the growth of children under five years of age in low and middle income countries.
|
Cochrane Database Syst Rev
|
2012
|
0.99
|
|
35
|
Blood pressure dynamics during pregnancy and spontaneous preterm birth.
|
Am J Obstet Gynecol
|
2007
|
0.98
|
|
36
|
Active management of the third stage of labour without controlled cord traction: a randomized non-inferiority controlled trial.
|
Reprod Health
|
2009
|
0.94
|
|
37
|
Nutritional interventions during pregnancy for the prevention or treatment of impaired fetal growth: an overview of randomized controlled trials.
|
J Nutr
|
2003
|
0.89
|
|
38
|
Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002.
|
J Clin Microbiol
|
2004
|
0.87
|
|
39
|
Elective induction versus spontaneous labour in Latin America.
|
Bull World Health Organ
|
2011
|
0.86
|
|
40
|
[The effect of early and delayed umbilical cord clamping on ferritin levels in term infants at six months of life: a randomized, controlled trial].
|
Arch Argent Pediatr
|
2010
|
0.84
|
|
41
|
Umbilical vein injection for management of retained placenta.
|
Cochrane Database Syst Rev
|
2011
|
0.82
|
|
42
|
Characteristics of randomized controlled trials included in systematic reviews of nutritional interventions reporting maternal morbidity, mortality, preterm delivery, intrauterine growth restriction and small for gestational age and birth weight outcomes.
|
J Nutr
|
2003
|
0.81
|
|
43
|
The tools and techniques of evidence-based medicine.
|
Best Pract Res Clin Obstet Gynaecol
|
2004
|
0.81
|
|
44
|
Effects of calcium supplementation on fetal growth in mothers with deficient calcium intake: a randomised controlled trial.
|
Paediatr Perinat Epidemiol
|
2010
|
0.81
|
|
45
|
Perinatal research in developing countries--is it possible?
|
Semin Fetal Neonatal Med
|
2006
|
0.80
|
|
46
|
WHO multicentre study for the development of growth standards from fetal life to childhood: the fetal component.
|
BMC Pregnancy Childbirth
|
2014
|
0.80
|
|
47
|
A cluster randomized controlled trial to evaluate the effectiveness of the clinically integrated RHL evidence -based medicine course.
|
Reprod Health
|
2010
|
0.79
|
|
48
|
Outcomes of non-vertex second twins, following vertex vaginal delivery of first twin: a secondary analysis of the WHO Global Survey on maternal and perinatal health.
|
BMC Pregnancy Childbirth
|
2014
|
0.78
|
|
49
|
Correction: The World Health Organization Fetal Growth Charts: A Multinational Longitudinal Study of Ultrasound Biometric Measurements and Estimated Fetal Weight.
|
PLoS Med
|
2017
|
0.77
|
|
50
|
Umbilical vein injection for the routine management of third stage of labour.
|
Cochrane Database Syst Rev
|
2012
|
0.77
|
|
51
|
Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials.
|
Semin Nephrol
|
2004
|
0.76
|
|
52
|
Alternative versus standard packages of antenatal care for low-risk pregnancy.
|
Cochrane Database Syst Rev
|
2015
|
0.76
|
|
53
|
The WHO Reproductive Health Library: a Cochrane window on sexual and reproductive health.
|
Cochrane Database Syst Rev
|
2013
|
0.75
|